Provided by Tiger Fintech (Singapore) Pte. Ltd.

Salarius Pharmaceuticals Inc

0.6770
+0.00530.79%
Post-market: 0.6600-0.0170-2.51%18:09 EDT
Volume:47.42K
Turnover:32.30K
Market Cap:1.18M
PE:-0.12
High:0.7099
Open:0.6400
Low:0.6400
Close:0.6717
Loading ...

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board

GlobeNewswire
·
16 Apr

BRIEF-Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses

Reuters
·
26 Mar

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising in Silico Activity Against Measles and Related Viruses

THOMSON REUTERS
·
26 Mar

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses

GlobeNewswire
·
26 Mar

Salarius Pharmaceuticals 2024 EPS $(5.79) vs $(30.74) YoY

Benzinga
·
24 Mar

Press Release: Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update

Dow Jones
·
24 Mar

Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-Initiated Phase 1/2 Clinical Trial Using Seclidemstat With Azacitidine to Treat Hematologic Cancers

THOMSON REUTERS
·
03 Feb

Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers

GlobeNewswire
·
03 Feb

Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge

Benzinga
·
14 Jan

Top Midday Gainers

MT Newswires Live
·
14 Jan

Salarius Pharma Shares More than Double on Merger Deal With Decoy Therapeutics

MT Newswires Live
·
14 Jan

BRIEF-Salarius Pharmaceuticals And Decoy Therapeutics Announce Definitive Merger Agreement

Reuters
·
13 Jan

Salarius Pharmaceuticals to Merge with Decoy Therapeutics

Dow Jones
·
13 Jan

Salarius Pharmaceuticals Inc - New Board to Include Rick Pierce, Barbara Hibner, and Three Independent Directors

THOMSON REUTERS
·
13 Jan

Salarius Pharmaceuticals Inc - Combined Company to Be Led by Decoy's Co-Founders

THOMSON REUTERS
·
13 Jan

Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement

THOMSON REUTERS
·
13 Jan

Salarius Pharmaceuticals Inc - Newly Formed Company to Be Named Decoy Therapeutics

THOMSON REUTERS
·
13 Jan

Salarius Pharmaceuticals Inc - Decoy Investors to Own 86% of Merged Company, Salarius Stockholders 14%

THOMSON REUTERS
·
13 Jan

Press Release: Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement

Dow Jones
·
13 Jan

BRIEF-Salarius Pharmaceuticals Enters Securities Purchase Agreement

Reuters
·
13 Dec 2024